Heart disease is a global pandemic affecting 26 million worldwide and increasing in prevalence. More effective front-line tools are needed to identify patients earlier while lowering costs for health systems. Current conventional ECG/EKG testing, the key front-line tool, has significant limitations ...See more
Headquarter United States of America |
Countries of operation Singapore, United States of America |
Year founded 2008 (16 years) |
Funding status Publicly listed on stock exchange |
Company type MNC / Large Enterprise |
Director Business Development - APAC